GLP-1 medications for weight loss are becoming so common that most of us know someone taking oneor are taking one ourselves
In January 2026, an IGD ShopperVista report found that 5.2% of respondents say they have personally used weight loss drugs, an increase of 1% from September 2025
We dont have many options for this group apart from Topiramate and Metformin
Read clinical review Evidence-based review of how Zepbound (tirzepatide) safety, tolerability, dosing, and pharmacokinetics differ in East Asian populations, including SURMOUNT and SURPASS-J trial data
But once I started taking a GLP-1, I was down for the count till lunchtime. And that was after just one or two drinks
Young has also served on clinical faculty at the University of Missouri-Kansas City School of Medicine and contributed to multiple publications and presentations in plastic surgery